Inovio Pharmaceuticals, Inc. (INO) vs Neonc Technologies Holdings, Inc. (NTHI)

A side-by-side comparison of Inovio Pharmaceuticals, Inc. and Neonc Technologies Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

INO

Inovio Pharmaceuticals, Inc.

$78M

$1.13HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

NTHI

Neonc Technologies Holdings, Inc.

$78M

$2.99HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — INO vs NTHI

growth of $100 · dividends reinvested · last 1y

INO -27.2% (-27.2%/yr)NTHI -69.7% (-69.7%/yr)INO compounded faster over this window

INO NTHI

INO vs NTHI: by the numbers

•INO is the larger company ($78M vs $78M market cap).
•Both run net losses; INO's is the smaller (-130000.00% vs -155404.38% net margin).

Metrics side by side

Valuation

Metric	INO	NTHI
P/B ratio	17.86	N/A

Profitability

Metric	INO	NTHI
Gross margin	100.00%	100.00%
Operating margin	-132871.32%	-145459.36%
Net margin	-130000.00%	-155404.38%
ROE	-1542.57%	N/A
ROIC	-836.58%	N/A

Growth (annualized)

Metric	INO	NTHI
Total return CAGR (5Y)	-57.05%	N/A

Go deeper

Full INO analysis Full NTHI analysis Interactive comparison tool

Dig into the metrics

Inovio Pharmaceuticals ROE Neonc Technologies ROE Inovio Pharmaceuticals operating margin Neonc Technologies operating margin Inovio Pharmaceuticals revenue growth Neonc Technologies revenue growth Inovio Pharmaceuticals free cash flow Neonc Technologies free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.